These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26414185)

  • 1. Platelet transfusion and respecting patient D type.
    Cid J; Yazer MH; Lozano M
    Curr Opin Hematol; 2015 Nov; 22(6):540-6. PubMed ID: 26414185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-RH1 (anti-D) alloimmunization after transfusion of platelet concentrates from RH :1 donors].
    Duboeuf S; Flourié F; Courbil R; Oriol P; Benamara A; Chartier M; Rigal E; Garraud O
    Ann Biol Clin (Paris); 2009; 67(3):353-7. PubMed ID: 19411240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigation strategies for anti-D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN
    Poston JN; Sugalski J; Gernsheimer TB; Marc Stewart F; Pagano MB
    Vox Sang; 2020 May; 115(4):334-338. PubMed ID: 32080868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.
    Cid J; Lozano M; Ziman A; West KA; O'Brien KL; Murphy MF; Wendel S; Vázquez A; Ortín X; Hervig TA; Delaney M; Flegel WA; Yazer MH;
    Br J Haematol; 2015 Feb; 168(4):598-603. PubMed ID: 25283094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients.
    Cid J; Carbassé G; Pereira A; Sanz C; Mazzara R; Escolar G; Lozano M
    Transfusion; 2011 Jun; 51(6):1163-9. PubMed ID: 21126258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D+ platelet transfusions in D- patients: cause for concern?
    Bartley AN; Carpenter JB; Berg MP
    Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates?
    Atoyebi W; Mundy N; Croxton T; Littlewood TJ; Murphy MF
    Br J Haematol; 2000 Dec; 111(3):980-3. PubMed ID: 11122163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive anti-C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series.
    Sostin N; Ross R; Balbuena-Merle R; Hendrickson JE; Tormey CA
    J Clin Apher; 2020 Jun; 35(3):224-226. PubMed ID: 32110829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG.
    Ayache S; Herman JH
    Transfusion; 2008 Sep; 48(9):1990-9. PubMed ID: 18564395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprophylaxis using intravenous Rh immune globulin should be standard practice when selected D-negative patients are transfused with D-positive random donor platelets.
    Ewing CA; Rumsey DH; Langberg AF; Sandler SG
    Immunohematology; 1998; 14(4):133-7. PubMed ID: 15377177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet transfusion and immunization anti-Rh1: implication for immunoprophylaxis].
    Chambost H
    Transfus Clin Biol; 2014 Nov; 21(4-5):210-5. PubMed ID: 25282489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-D immunization after D positive platelet transfusions in D negative recipients: A systematic review and meta-analysis.
    Hubert T; Kerkhoffs JL; Brand A; Schonewille H
    Transfusion; 2024 May; 64(5):933-945. PubMed ID: 38634345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study.
    Selleng K; Jenichen G; Denker K; Selleng S; Müllejans B; Greinacher A
    Lancet Haematol; 2017 May; 4(5):e218-e224. PubMed ID: 28389344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet transfusion in an infant leading to formation of anti-D: implications for immunoprophylaxis.
    Haspel RL; Walsh L; Sloan SR
    Transfusion; 2004 May; 44(5):747-9. PubMed ID: 15104657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predisposing factors for anti-D immune response in D
    Burin des Roziers N; Chadebech P; Malard L; Vingert B; Gallon P; Samuel D; Djoudi R; Fillet AM; Pirenne F
    Transfusion; 2019 Apr; 59(4):1353-1358. PubMed ID: 30604873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions.
    Cid J; Ortin X; Elies E; Castellà D; Panadés M; Martín-Vega C
    Transfusion; 2002 Feb; 42(2):173-6. PubMed ID: 11896331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of anti-D to improve post-transfusion platelet response: a randomized trial.
    Heddle NM; Klama L; Kelton JG; Meyer R; Walker I; Dickson L; Chambers S; Levine MN
    Br J Haematol; 1995 Jan; 89(1):163-8. PubMed ID: 7833257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-D alloimmunization after D-incompatible platelet transfusions: a 14-year single-institution retrospective review.
    O'Brien KL; Haspel RL; Uhl L
    Transfusion; 2014 Mar; 54(3):650-4. PubMed ID: 23829356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.